Slide

Press Releases

Press Releases

United Orthopedic Corporation Wins Bronze at 21st Annual Medical Design Excellence Awards

U2 Knee AiO™ Block and MDT™ Recognized as Significant Achievements Among Implant and Tissue-Replacement Products California, June 12, 2019 – United Orthopedic Corporation (UNITED), a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, today announced that its U2 Knee AiO™ Block and Modular Disposable TrialTM (MDT) have earned UNITED a Bronze award in the 21st Annual Medical Design Excellence Awards (MDEA). The U2 Knee AiO Block and MDT were recognized as significant achievements in the “Implant and Tissue-Replacement Product” category. “On behalf of the design and engineering team, we are honored to have had our U2 Knee AiO Block and MDT selected by the MDEA for this prestigious award,” said Jason Lin, Chairman and CEO of United Orthopedic Corporation. “As innovators striving to create a more efficient and precise environment within operating rooms across the orthopedic space, we take great pride

THINK Surgical and United Orthopedic Corporation Announce Collaboration to Deliver Enhanced Precision and Pursue Reproducible Outcomes in Total Knee Replacements

E-XPETM Designed to Provide Wear Resistance with Reduced Risk of Oxidation is Now Available in Both Knee Inserts and Hip Liners IRVINE, Calif., November 27, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced that the U.S. Food and Drug Administration has cleared its vitamin E highly cross-linked polyethylene (E-XPETM) hip liner. The E-XPETM is the new generation of highly cross-linked polyethylene blended with vitamin E to enhance wear resistance without compromising oxidative stability and mechanical properties. “Oxidation continues to be a concern for surgeons. Over time, wear of conventional polyethylene can generate debris in the joint, triggering local inflammation that results in bone loss which is one of the biggest causes of late-term failure in hip and knee replacements,” said Calvin Lin, President of United Orthopedic Corporation USA. “Clearance of our E-XPETM, a vitamin E

United Orthopedic Corporation Announces FDA Clearance for Vitamin E Highly Cross-Linked Polyethylene Hip Liner

E-XPETM Designed to Provide Wear Resistance with Reduced Risk of Oxidation is Now Available in Both Knee Inserts and Hip Liners IRVINE, Calif., November 27, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced that the U.S. Food and Drug Administration has cleared its vitamin E highly cross-linked polyethylene (E-XPETM) hip liner. The E-XPETM is the new generation of highly cross-linked polyethylene blended with vitamin E to enhance wear resistance without compromising oxidative stability and mechanical properties. “Oxidation continues to be a concern for surgeons. Over time, wear of conventional polyethylene can generate debris in the joint, triggering local inflammation that results in bone loss which is one of the biggest causes of late-term failure in hip and knee replacements,” said Calvin Lin, President of United Orthopedic Corporation USA. “Clearance of our E-XPETM, a vitamin E

United Orthopedic Corporation Announces UTS™ Hip Stem and an Extension of its U-Motion II™ Acetabular System Are Now Available

IRVINE, Calif., November 1, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced that the UTS™ (United Tri-tapered Short Stem) hip stem and an extension of the U-Motion II™ Acetabular System are now available to surgeons in the U.S. “The UTS hip stem and U-Motion II extension reflect our commitment to addressing some of the challenges in today’s hip replacement market – reducing dislocations and providing solutions that support rapid recovery from surgery,” said Calvin Lin, President of United Orthopedic Corporation USA. “Since the launch of these products at this year’s American Academy of Orthopaedic Surgeons Annual Meeting, we have received positive feedback from orthopedic surgeons, citing easier insertion of the hip stem, greater range of motion and improved stability.” The UTS hip stem is a tapered wedge short stem suitable for less invasive

United Orthopedic Corporation Launches UTSTM Hip Stem and an Extension of its U-Motion IITM Acetabular System at the American Academy of Orthopaedic Surgeons Annual Meeting

IRVINE, Calif., March 7, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, announced today, at the American Academy of Orthopaedic Surgeons Annual Meeting in New Orleans, the launch of the UTSTM (United Tri-tapered Short Stem) hip stem and an extension of the U-Motion IITM Acetabular System. “We are committed to developing quality, innovative orthopedic products that improve patient outcomes and address the market’s needs,” said Calvin Lin, President of United Orthopedic Corporation USA. “Our unique vertically integrated manufacturing model has enabled us to launch two products which provide surgeons with more treatment options for total hip replacement. One is the UTSTM hip stem, which facilitates less invasive surgery and aids in rapid recovery. The other is a new cup and cup liner – an extension of the U-Motion IITM Acetabular System – which is designed to reduce the risk

United Orthopedic Corporation Announces First Patient Enrollment in Study of U2 Knee™ System

Study to Evaluate Clinical Performance of the System in Primary Total Knee Arthroplasty IRVINE, Calif., May 23, 2017 – United Orthopedic Corporation (UOC), a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, today announced the launch of a primary total knee arthroplasty (TKA) trial. Entitled “Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System – ‘U Propel Study’,” the trial recently enrolled its first patient. This prospective, single arm, multi-center, post-market study will evaluate the short- and long-term clinical performance, and implant survivorship of the commercially available U2 Knee™ System in subjects receiving primary TKA. “We were extremely confident with the execution and success of the first U2 Knee System replacement,” said David Cashen, MD, principal study investigator and practicing orthopedic surgeon at Coastal Orthopedics in Bradenton, Fla. “One day after surgery our patient is ambulating independently, performing

United Orthopedic Corporation Receives U.S. FDA Clearance for Company’s Polyethylene Knee Insert

IRVINE, Calif., November 1, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced that the UTS™ (United Tri-tapered Short Stem) hip stem and an extension of the U-Motion II™ Acetabular System are now available to surgeons in the U.S. “The UTS hip stem and U-Motion II extension reflect our commitment to addressing some of the challenges in today’s hip replacement market – reducing dislocations and providing solutions that support rapid recovery from surgery,” said Calvin Lin, President of United Orthopedic Corporation USA. “Since the launch of these products at this year’s American Academy of Orthopaedic Surgeons Annual Meeting, we have received positive feedback from orthopedic surgeons, citing easier insertion of the hip stem, greater range of motion and improved stability.” The UTS hip stem is a tapered wedge short stem suitable for less invasive

United Orthopedic Corporation (UOC) Donates Orthopedic Replacement Systems to Hospital in China

IRVINE, Calif., November 1, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced that the UTS™ (United Tri-tapered Short Stem) hip stem and an extension of the U-Motion II™ Acetabular System are now available to surgeons in the U.S. “The UTS hip stem and U-Motion II extension reflect our commitment to addressing some of the challenges in today’s hip replacement market – reducing dislocations and providing solutions that support rapid recovery from surgery,” said Calvin Lin, President of United Orthopedic Corporation USA. “Since the launch of these products at this year’s American Academy of Orthopaedic Surgeons Annual Meeting, we have received positive feedback from orthopedic surgeons, citing easier insertion of the hip stem, greater range of motion and improved stability.” The UTS hip stem is a tapered wedge short stem suitable for less invasive

United Orthopedic Corporation Announces Enrollment of First U.S. Patient in Hip Replacement System Follow-Up Study

Company Initiates U.S. Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem for Patients Who Require Primary Total Hip Arthroplasty IRVINE, Calif., February 23, 2016 — United Orthopedic Corporation (UOC), a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced the start of patient enrollment in a follow-up study in the U.S. of the commercially available U-Motion II+ Acetabular System and UTF Reduced Stem in patients receiving primary total hip arthroplasty (THA). The prospective, single arm, multi-center, post-approval study is designed to evaluate the short and long-term clinical performance of the devices, which are designed to improve hip flexion, reduce the risk of joint dislocation and allow for minimal bone removal during THA procedures. “Despite numerous advances in hip replacement technology, issues such as postoperative dislocation, bearing wear and insufficient range of motion remain challenging problems,

United Orthopedic Corporation Enters U.S. Market

International leader brings FDA-approved hip and knee replacement products to American orthopedic surgeons. IRVINE, Calif.—Today, United Orthopedic Corporation (UOC) – a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments – announced its entrance into the American market, offering clinically proven, safe and cost-effective hip and knee devices through its U.S. subsidiary, UOC USA. “United Orthopedic Corporation is the first Asian orthopedic company to receive FDA approval for join reconstruction,” said Calvin Lin, president of UOC USA. “For the past 20 years we’ve been recognized for our innovative products and we are excited to bring our high-performing line of hip and knee replacement systems to American orthopedic surgeons.” Established in 1993 and headquartered in Taiwan, UOC has been supplying and supporting orthopedic practitioners and institutions around the world with arthroplasty implant and instrument designs created by its vertically integrated, in-house manufacturing team.

Scroll to Top